R&D | January 16, 2026
Redesigned brain receptor drugs show promise for depression
The researchers removed a chemical group commonly used in previous NK1R drugs and replaced it with a novel molecular scaffold
The researchers removed a chemical group commonly used in previous NK1R drugs and replaced it with a novel molecular scaffold
The launch of PatroLab is a pivotal milestone, marking a paradigm shift in biologics development and manufacturing
Iktos will deploy its AI-driven tools to accelerate the identification of optimized small-molecule candidates against a currently undisclosed oncology target
The integration unifies brand and field strategy, drives executional alignment, and delivers immediate impact measurement
The guidelines also support reusing tenofovir and abacavir in later regimens for improved outcomes, cost savings, and programmatic efficiency
The therapy was well tolerated through Week 24, with a safety profile consistent with Alumis’ Phase 2 data
Blood tests measuring biomarkers such as p-tau217 are emerging as accurate, accessible alternatives
Sovaaka offers a deeply personalised diagnostics-led wellness experience that goes beyond routine health checks
Subscribe To Our Newsletter & Stay Updated
